Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?

Newell ML, Patel D, Goetghebuer T, Thorne C; European Collaborative Study..

J Infect Dis. 2006 Apr 1;193(7):954-62. Epub 2006 Feb 23.

PMID:
16518757
2.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
3.

Current and future antiretroviral treatment options in paediatric HIV infection.

Giaquinto C, Morelli E, Fregonese F, Rampon O, Penazzato M, de Rossi A, D'Elia R.

Clin Drug Investig. 2008;28(6):375-97. Review.

PMID:
18479179
4.

API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.

Gupta SB, Pujari SN, Joshi SR, Patel AK; AIDS Society of India Guidelines Development Committee..

J Assoc Physicians India. 2006 Jan;54:57-74. Review.

PMID:
16649742
5.

Sepsis predisposition in children with human immunodeficiency virus.

Hatherill M.

Pediatr Crit Care Med. 2005 May;6(3 Suppl):S92-8. Review.

PMID:
15857567
6.

Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.

Puthanakit T, Bunupuradah T.

Curr Opin HIV AIDS. 2010 Jan;5(1):12-7. doi: 10.1097/COH.0b013e3283339b27. Review.

PMID:
20046143
7.

[Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers].

Ramos JT, de José MI, Polo R, Fortuny C, Mellado MJ, Muñoz-Fernández MA, Beceiro J, Bertrán JM, Calvo C, Chamorro L, Ciria L, Guillén S, González-Montero R, González-Tomé MI, Gurbindo MD, Martín-Fontelos P, Martínez-Pérez J, Moreno D, Muñoz-Almagro MC, Mur A, Navarro ML, Otero C, Rojo P, Rubio B, Saavedra J; Grupo Colaborativo Español de VIH Pediátrico (CEVIHP).; Sociedad Española de Infectologia Pediátrica (SEIP).; Asociacion Española de Pediatría (AEP).; Plan Nacional sobre el SIDA del Ministerio de Sanidad y Consumo..

Enferm Infecc Microbiol Clin. 2005 May;23(5):279-312. Review. Spanish.

PMID:
15899180
8.

Clinical and biological disease progression in vertically acquired paediatric HIV infection.

Gray L.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):437-48. Review.

PMID:
15010554
9.

Review of recent guidelines for antiretroviral treatment of HIV-infected children.

Oleske JM.

Top HIV Med. 2003 Nov-Dec;11(6):180-4. Review. No abstract available.

10.

Children with HIV: improved mortality and morbidity with combination antiretroviral therapy.

Foster C, Lyall EG.

Curr Opin Infect Dis. 2005 Jun;18(3):253-9. Review.

PMID:
15864104
11.

CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies.

Maina EK, Bonney EY, Bukusi EA, Sedegah M, Lartey M, Ampofo WK.

Immunol Lett. 2015 Dec;168(2):279-84. doi: 10.1016/j.imlet.2015.10.005. Epub 2015 Oct 22. Review.

PMID:
26475399
12.

Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.

Cotugno N, Douagi I, Rossi P, Palma P.

Clin Dev Immunol. 2012;2012:805151. doi: 10.1155/2012/805151. Epub 2012 Apr 8. Review.

13.

The implications of HIV for the anaesthetist and the intensivist.

Avidan MS, Jones N, Pozniak AL.

Anaesthesia. 2000 Apr;55(4):344-54. Review.

14.

Antiretroviral drugs in pediatrics.

Rongkavilit C, Asmar BI.

Indian J Pediatr. 2001 Jul;68(7):641-7. Review.

PMID:
11519288
15.

Treatment of HIV infection: Swedish recommendations 2009.

Josephson F, Albert J, Flamholc L, Gisslén M, Karlström O, Moberg L, Navér L, Svedhem V, Svennerholm B, Sönnerborg A; Swedish Medical Products Agency.; Swedish Reference Group for Antiviral Therapy..

Scand J Infect Dis. 2009;41(11-12):788-807. doi: 10.3109/00365540903214322. Review.

PMID:
19922061
16.

HIV treatment models with time delay.

Bachar M, Dorfmayr A.

C R Biol. 2004 Nov;327(11):983-94. Review.

PMID:
15628221
17.

HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes.

Delva W, Eaton JW, Meng F, Fraser C, White RG, Vickerman P, Boily MC, Hallett TB.

PLoS Med. 2012;9(7):e1001258. doi: 10.1371/journal.pmed.1001258. Epub 2012 Jul 10. Review.

18.

START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection.

Siedner MJ.

Open Forum Infect Dis. 2016 Feb 9;3(1):ofw032. doi: 10.1093/ofid/ofw032. eCollection 2016 Jan. Review.

Supplemental Content

Support Center